Welcome to LookChem.com Sign In|Join Free

CAS

  • or

220093-41-4

Post Buying Request

220093-41-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

220093-41-4 Usage

Properties

1. Chemical compound with a complex molecular structure
2. Form of the amino acid proline
3. Used in organic synthesis and pharmaceutical research
4. Chiral building block in the synthesis of pharmaceuticals and biological compounds

Specific content

1. Name: 2-Azabicyclo[2.2.1]heptane-3-carboxylic acid, methyl ester, (1R,3S,4S)-rel-(9CI)
2. Molecular structure: Complex and chiral
3. Usage: Organic synthesis and pharmaceutical research
4. Role: Valuable tool for creating complex chemical compounds and studying biological processes

Check Digit Verification of cas no

The CAS Registry Mumber 220093-41-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,0,9 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 220093-41:
(8*2)+(7*2)+(6*0)+(5*0)+(4*9)+(3*3)+(2*4)+(1*1)=84
84 % 10 = 4
So 220093-41-4 is a valid CAS Registry Number.

220093-41-4Downstream Products

220093-41-4Relevant articles and documents

MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES

-

, (2021/11/06)

The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.

Method for reducing content of diastereoisomer impurity in Ledipasvir intermediate

-

Paragraph 0044; 0045; 0046; 0047, (2016/10/10)

The invention discloses a method for reducing content of a diastereoisomer impurity (Ia) in a Ledipasvir intermediate (1R,3S,4S)-N-t-butyloxycarboryl-2-azabicyalo[2.2.1]heptane-3-carboxylic acid (I). The method comprises the steps of firstly taking a crude product of a compound shown as a formula (I) and containing the diastereoisomer impurity (Ia), dissolving in an organic solvent, adding alkaline organic amine to react with the crude product, separating out a solid, and filtering to obtain an amine salt of the compound shown as the formula (I); acidizing the obtained amine salt in an aqueous phase solution; extracting an obtained aqueous phase, separating out a solid, and separating to obtain the high-purity Ledipasvir intermediate (I). The product obtained by the method has a de value up to more than 99.5 percent, and the yield of more than 80 percent; reaction conditions in the method are mild, raw materials are easy to get, and the method is suitable for industrial application.

Direct asymmetric aldol reactions promoted by (1R, 3S, 4S)-2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid as an organocatalyst

Chen, Wei-Yi

, p. 378 - 380 (2015/03/03)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 220093-41-4